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ABSTRACT
We analyzed bacterial modulation of miRNAs in bone-marrow-
derived macrophages (BMMs) induced by infection with either wild 
type Porphyromonasgingivalis (Pg) or mutant Pg (∆FimA), through a 
microarray analysis. TNF-α and IL-10 concentrations in Pg infected 
BMMs transfected with selected miRNAs were also assessed. The 
inhibition of mmu-miR-2137 increased the secretion of anti-
inflammatory IL-10, while mmu-miR-155-5p decreased TNF-α. In 
vivo: injecting these miRNAs with Pg in mice reduced the size of the 
lesion significantly. 
INTRODUCTION
Periodontitis (PD) is a common chronic inflammatory disease 
inducing tooth-supporting tissue destruction (1) related to the 
dysbiosis of periodontal microbiota, associated with Pg. Macrophages 
are directly in contact with infectious agents or their byproducts (2). 
miRNAs are involved in many physiological and pathological 
processes (3). The expression and role of miRNAs in inflammatory 
and infectious diseases are not fully understood yet.
AIM OF THE STUDY
METHODS
Finding miRNAs that could be a potential therapeutic target and 
analyzing their biological effects. Particularly, the ones that affect 
the immune host-response in relation to Pg infection.
Wild type and mutant Pg were 
utilized to infect BMMs. In 
the animal module only wild 
type tested. (7)
Murine bone marrow drive macrophages were 
collected for the study. L929 (M-CSF) 
stimulate hematopoietic stem cell into 
macrophages. (4)
miRNA expression monitored 
using microarray analysis. (5) 
ELISA technique were used to 
assess the level of cytokines in 
BMMs infected with Pg. (6)
In calvarial bone-resorption mouse-
module, effect of two miRNA was 
confirmed after Pg infection.
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RESULTS
CONCLUSIONS
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pathogenicity of Pg in PD. This is supported by the decrease in TNF-α secretion 
when BMMs were transfected with this miRNA in vitro, and the reduction of 
inflammation in vivo. Inhibition of miRNA-2137 in vitro increased IL-10 secretion. 
More importantly, the inhibition of miRNA 2137 lead to significantly reduced 
inflammation in vivo.
Further research in this field may potentially lead to the identification of new 
therapeutics miRNA aiming to reduce the manipulation of invasive bacteria on host-
immune, which in turn reduce bacterial survival. 
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Figure 1: Heatmap of 
differentially expressed miRNA
of all of the conditions tested.
Red and blue indicate z-scores of 
≥ 2 or ≤ -2, respectively, and white 
indicates a z-score of 0 (row-wise 
mean). p and q ≤0.001.
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Figure 2: TNF-α. Dosage of TNF-α in 
supernatants of transfected BMMs infected with Pg
at 24h. * p<0.05. All in vitro experiments were 
performed in triplicate.
Figure 3: IL-10. Dosage of IL-10 in 
supernatants of transfected BMMs infected with 
Pg at 24h. * p<0.05. All in vitro experiments 
were performed in triplicate.
Figure 4: Size of 
Lesions. Size of 
calvarial lesions 7 d 
after Pg (5x108 CFU) 
infection and the 
injection of the mmu-
miR-155-5p mimic 
and mmu-miR-2137 
inhibitor. * p<0.05, 
n=4.
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Figure 5: Histological Sections. 
Representative samples for skin & underlying  
calvarias bone at the middle of the lesion 
from each group. Sample from  Pg (A-C); Pg
+ combination of miRNA (D-F); Pg + mmu-
miRNA 2137 inhibitor (G-I); and Pg + mmu-
miR 155 mimic (L-N). TRAP staining for 
bone (bottom raw 200x) and H&E staining 
for the skin (Top 100x and middle 200x raw)
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Figure 1: Heatmap of 
differentially expressed miRNA
of all of the conditions tested.
Red and blue indicate z-scores of 
≥ 2 or ≤ -2, respectively, and 
white indicates a z-score of 0 
(row-wise mean). p and q ≤0.001.
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Figure 2: TNF-α. Dosage of TNF-α in supernatants of transfected 
BMMs infected with Pg at 24h. * p<0.05. All in vitro experiments 
were performed in triplicate.
Figure 3: IL-10. Dosage of IL-10 in supernatants of 
BMMs infected with Pg at 24h. * p<0.05. All in vitro 
experiments were performed in transfected triplicate.
0
200
400
600
800
1000
1200
1400
pg
/m
l
TNF-α
02
4
6
8
10
12
14
Size	of	 the	 les ion	 (mm2)
*
*
Size of the Lesion (mm²)
Figure 4: Size of Lesions. Size of 
calvarial lesions 7 d after Pg (5x108 
CFU) infection and the injection of 
the mmu-miR-155-5p mimic and 
mmu-miR-2137 inhibitor. * p<0.05, 
n=4.
Figure 5: Histological Sections. Representative samples for skin & underlying calvarial bone at the middle of the lesion from each 
of the following groups: Pg (A-C); Pg + combination group (D-F); Pg + anti-miRNA-2137 (G-I); and Pg + miR 155 (L-N). TRAP 
staining for bone (bottom row, 200x) and H&E staining for the skin (Top row, 100x; middle row, 200x). Arrows indicate TRAP 
stained multi-nucleated osteoclasts attached to the bone and bone resorption lacunae.
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